Compare Alcon AG (ALC) vs F5 Inc (FFIV) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Alcon AG vs F5 Inc — how do they compare? Alcon AG trades at $66.64 (market cap $32.69B), while F5 Inc trades at $419.14 (market cap $23.53B). The key difference: Alcon AG is the larger of the two by market cap, and Alcon AG pays a 0.54% dividend while F5 Inc pays none. Which is the better fit depends on your goals.
| ALC | FFIV | |
|---|---|---|
Market Cap | $32.69B | $23.53B |
Sector | Health | Technology |
52-Week High | $92.22 | $424.18 |
52-Week Low | $62.02 | $223.99 |
Enterprise Value | $36.28B | $22.35B |
Dividend Yield | 0.54% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALC trades at $66.87, down 4.01% on the day, amid a mixed technical and fundamental backdrop. The stock exhibits a bullish technical signal overall, with moving averages supporting a positive trend, while oscillators remain neutral. Fundamentally, revenue growth is steady, reaching $10.40 billion in 2025, though net income margin compressed to 7.7%. Recent news highlights product innovation, including a collaboration with RxSight for adjustable PCIOLs, signaling ongoing R&D investment. Analyst sentiment is predominantly positive, with a consensus price target of $86.00 implying significant upside.
The outlook for ALC is cautiously optimistic, driven by new product launches and strategic partnerships that may fuel growth. However, risks include competitive pressures, macroeconomic headwinds, and margin compression. With a P/E of 40.92, the valuation appears rich relative to historical norms, requiring strong earnings delivery to justify current levels. Investors should weigh robust analyst buy ratings against execution risks and market volatility.
F5 (FFIV) trades at $417.11, up 2.16% on the day, reflecting strong momentum after three consecutive quarterly earnings beats. The stock is technically bullish, trading above key support levels, while fundamentals show robust revenue growth to $3.09B in 2025 and a high net income margin of 21.96%. Recent strategic moves include expanding AI security offerings through acquisitions and partnerships, positioning the company in the high-growth cybersecurity sector.
The outlook remains positive given consistent earnings outperformance and strategic focus on AI security, though valuation multiples like a P/E of 34.42 suggest premium pricing. Risks include competitive pressures and execution challenges in integrating new technologies. Analyst consensus is mixed with a $397 price target slightly below current levels, indicating cautious optimism amid growth prospects.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About F5 Inc
F5 is a market leader in the application delivery controller market. The company sells products for networking traffic, security, and policy management. Its products ensure applications are safely routed in efficient manners within on-premises data centers and across cloud environments. More than half of its revenue is based on providing services, and its three customer verticals are enterprises, service providers, and government entities. The Seattle-based firm was incorporated in 1996 and generates sales globally.
Read more on FFIV →
